Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Emil D Kakkis
11 Sep 2019
President & CEO
Buy
5,000
$43.63
$218.15K
Emil D Kakkis
28 Aug 2017
President & CEO
Buy indirect
1,647
$52.96
$87.23K
Emil D Kakkis
28 Aug 2017
President & CEO
Buy indirect
5,853
$52.40
$306.70K

What was left out

Form 4 filings counted 449
Amendments (4/A) skipped 11
Filings about a different issuer 3
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 28
Sales straight out of an exercise 57
Sales at will 149
Transactions with no price 0
Shares from compensation/vesting 3,103,818
Sales filed before the plan box existed 100
History held since 3 Feb 2014